13 November 2025

Virometix raises USD 15M

Virometix develops synthetic vaccines against infectious diseases.

Entities

Virometix

Company · Schlieren

Website Map

More news

9 Oct

One-hour treatment improves blood stem cell transplants in mice

UZH researchers treated human blood stem cells with a protein for one hour, improving their ability to regenerate blood after transplantation into mice.

Research Biotech

24 Sept

Prevision Medicine raises USD 5.4M seed

Prevision Medicine has raised USD 5.4M to commercialise its cancer-treatment testing platform. Instead of relying only on how similar patients responded, the test exposes living cells from a patient's tumour to a library of treatments and measures their response. The Zurich company plans to use the funding for regulatory clearances, reimbursement coverage and expansion across Europe. Its PrevisionOne test is intended to help clinicians evaluate treatment options for blood cancers and solid tumours, using measurements from the individual patient's cells.

Funding Biotech

Menu

Virometix raises USD 15M

Confirm

Install zurich.tech